"Atlantic Gastroenterology Associates (AGA) is on the cutting edge of gastrointestinal diagnosis and treatment. Established in 1979 as a small southern New Jersey practice, AGA has flourished to become the largest and most sophisticated gastrointestinal treatment center in three counties. The skilled and compassionate patient care found at AGA is enhanced by breakthrough diagnostic tools that use miniaturized technology to make diagnosing GI conditions more accurate and comprehensive—yet less invasive—than ever before. Board certified and nationally recognized gastroenterologists, nurse practitioners and over 40 support personnel care for more than 5,000 patients each year."

During the past decade, AGA Clinical Research Associates, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AGA Clinical Research Associates, LLC" #1 sponsor was "Allergan" with 4 trials, followed by "Exact Sciences Corporation" with 4 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Enanta Pharmaceuticals, Inc" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AGA Clinical Research Associates, LLC" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Cell Pathways" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "AGA Clinical Research Associates, LLC" are "Crohn's Disease" (6 trials), "Colorectal Cancer" (4 trials), "Gastroparesis" (4 trials), "Ulcerative Colitis" (4 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "AGA Clinical Research Associates, LLC" in a lesser frequency.

Most popular intervention types in "AGA Clinical Research Associates, LLC" are "Drug" (27 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Relamorelin" (3 trials), "Filgotinib" (2 trials), "GED-0301" (2 trials) and "Vedolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "AGA Clinical Research Associates, LLC" are 31 trials for "All" genders.

Currently, there are NaN active trials in "AGA Clinical Research Associates, LLC". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in AGA Clinical Research Associates, LLC, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in AGA Clinical Research Associates, LLC, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".